Cargando…
Current Therapeutic Options in the Treatment of Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic inflammation of the joints. Untreated RA leads to a destruction of joints through the erosion of cartilage and bone. The loss of physical function is the consequence. Early treatment is important to control disease a...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678427/ https://www.ncbi.nlm.nih.gov/pubmed/31261785 http://dx.doi.org/10.3390/jcm8070938 |
_version_ | 1783441098391158784 |
---|---|
author | Köhler, Birgit M. Günther, Janine Kaudewitz, Dorothee Lorenz, Hanns-Martin |
author_facet | Köhler, Birgit M. Günther, Janine Kaudewitz, Dorothee Lorenz, Hanns-Martin |
author_sort | Köhler, Birgit M. |
collection | PubMed |
description | Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic inflammation of the joints. Untreated RA leads to a destruction of joints through the erosion of cartilage and bone. The loss of physical function is the consequence. Early treatment is important to control disease activity and to prevent joint destruction. Nowadays, different classes of drugs with different modes of action are available to control the inflammation and to achieve remission. In this review, we want to discuss differences and similarities of these different drugs. |
format | Online Article Text |
id | pubmed-6678427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-66784272019-08-19 Current Therapeutic Options in the Treatment of Rheumatoid Arthritis Köhler, Birgit M. Günther, Janine Kaudewitz, Dorothee Lorenz, Hanns-Martin J Clin Med Review Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic inflammation of the joints. Untreated RA leads to a destruction of joints through the erosion of cartilage and bone. The loss of physical function is the consequence. Early treatment is important to control disease activity and to prevent joint destruction. Nowadays, different classes of drugs with different modes of action are available to control the inflammation and to achieve remission. In this review, we want to discuss differences and similarities of these different drugs. MDPI 2019-06-28 /pmc/articles/PMC6678427/ /pubmed/31261785 http://dx.doi.org/10.3390/jcm8070938 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Köhler, Birgit M. Günther, Janine Kaudewitz, Dorothee Lorenz, Hanns-Martin Current Therapeutic Options in the Treatment of Rheumatoid Arthritis |
title | Current Therapeutic Options in the Treatment of Rheumatoid Arthritis |
title_full | Current Therapeutic Options in the Treatment of Rheumatoid Arthritis |
title_fullStr | Current Therapeutic Options in the Treatment of Rheumatoid Arthritis |
title_full_unstemmed | Current Therapeutic Options in the Treatment of Rheumatoid Arthritis |
title_short | Current Therapeutic Options in the Treatment of Rheumatoid Arthritis |
title_sort | current therapeutic options in the treatment of rheumatoid arthritis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678427/ https://www.ncbi.nlm.nih.gov/pubmed/31261785 http://dx.doi.org/10.3390/jcm8070938 |
work_keys_str_mv | AT kohlerbirgitm currenttherapeuticoptionsinthetreatmentofrheumatoidarthritis AT guntherjanine currenttherapeuticoptionsinthetreatmentofrheumatoidarthritis AT kaudewitzdorothee currenttherapeuticoptionsinthetreatmentofrheumatoidarthritis AT lorenzhannsmartin currenttherapeuticoptionsinthetreatmentofrheumatoidarthritis |